Figure 5From: Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal StudyHeight standardized scores for females during the study. The pretreatment baseline is the mean standardized height score of patients before initiation of leuprolide acetate therapy. The height at the end of treatment refers to the mean standardized height score for patients at the end of the treatment period. Adult height includes standardized scores for those patients whose height was collected at adulthood after age 18. For those without adult height available, adult height was established when their growth velocity was <1 cm/year or bone age was ≥14 years during the follow-up period.Back to article page